Form 4 Filing for IMMUNIC, INC.

Robert Thorvald Nagel, a director at IMMUNIC, INC., acquired 25,370 stock options on September 16, 2026. The options have an exercise price of $10.12 and will expire on September 16, 2036. These options vest over one year from the grant date, with monthly increments. Mr. Nagel is affiliated with BVF Partners L.P. and is obligated to transfer the economic benefit of these shares to BVF, thus disclaiming beneficial ownership except to the extent of his pecuniary interest.